Fremont-based biopharmaceuticals developer
Ardelyx said Friday that it has received $110M in a private placement, which came from both new and existing investors, including New Enterprise Assocaites (NEA), plus Australia's Future Fund, Quadrille Capital, EcoR1 Capital, RA Capital Management, First Manhattan Co., Rock Springs Capital, Cormorant Asset Management, Perceptive Advisors, Deerfield and DAFNA Capital Management. The company said the funds goes towards Phase 3 development efforts. Ardelyx is listed on the NASDAQ as ARDX, and led by Mike Raab.
posted on Monday, July 18, 2016 (Link to more information)
Related companies:
ARDELYX, INC.
Related stories:
> Ardelyx Raises $30M
> Grammarly Picks Up $110M
> Sorenson Ventures Closes $110M Fund
> Akeena Adds $12.6M In PIPE
> Proofpoint Acquires Cloudmark For $110M
silicontap.com Home